Cardiorenal Risk with SGLT2i versus DPP4i in T2D Patients without Established Cardiovascular- and Renal Diseases: A Large Multinational Observational Study
ASN Congress
No DOI/URL available
Therapy areas:
Cardiovascular, Renal and Metabolism
Indications:
Diabetes Type 2
Mahar, E., Sprenger, R., Diesing, J., Kossack, N., Häckl, D. & Eiff, C. von. (2022).
Case Fatality Risk and Attributable Costs in Patients Treated for Community-Acquired Pneumonia in Germany: A Population-Based Healthcare Claims Data Cohort Study. [preprint].
SSRN Electronic Journal.
DOI:https://doi.org/10.2139/ssrn.4118607 (abgerufen am 30.10.2023).
Therapy areas:
Respiratory
Indications:
Pneumonia
Max Hilz, Nicole Lyn, Pronabesh DasMahapatra, Michael Edigkaufer, Elvira Ponce, Joseph Bender, Felix Marczykowski, Marc Pignot, Barbara Werner
Burden of Illness Among Treated and Untreated Patients with Fabry Disease in Germany: A Retrospective Claims Analysis of the German Sickness Fund Database;
World 2021
No DOI/URL available
Therapy areas:
Rare Disease
Indications:
Fabry Disease
K. Birkeland, J. Bodegard, J. Eriksson, A. Norhammar, M. Thuresson, M. Pignot, E. Garal-Pantaler, T. Yajima, I. Komuro, T. Kadowaki.
Cardiorenal disease is the most common first CV manifestation in type 2 diabetes and associated with increased mortality: a large multinational observational study.
European Association for the Study of Diabetes 55th Annual Meeting; 2019.
No DOI/URL available
Therapy areas:
Cardiovascular, Renal and Metabolism
Indications:
Diabetes Type 2
Dörte Anderson; Johan Bodegard MD PhD, Orm Proske MD PhD; Herman Haller MD PhD, Marcus Thuresson PhD, Elena Garal-Pantaler PhD, Marc Pignot PhD
Cardiorenal diseases are primary and life-threatening cardiovascular sequelae in type 2 diabetes patients: a secondary data analysis of the German BKK database
Diabetologie & Stoffwechsel
No DOI/URL available
Therapy areas:
Cardiovascular, Renal and Metabolism
Indications:
Diabetes Type 2
K.I. Birkeland, Johan Bodegard, Jan W Eriksson, Anna Norhammar, Marcus Thuresson, Marc Pignot, Elena Garal-Pantaler, Toshitaka Yajima, Issei Komuro, Takashi Kadowaki.
Cardiorenal disease is the most common first CV manifestation in type 2 diabetes and associated with increased mortality: a large multinational observational study.
EASD Congress 2019.
No DOI/URL available
Therapy areas:
Cardiovascular, Renal and Metabolism
Indications:
Diabetes Type 2
Neumann, A., Swart, E., Häckl, D., Küster, D., Kliemt, R., March, S., Arnold, K. & Petzold, T. (2016).
Bundesweit einheitliche wissenschaftliche Evaluation von Modellvorhaben nach §64b SGB V (EVA64) – Studiendesign. In: Deutsches Netzwerk Versorgungsforschung e. V. (Hrsg.).
15. Deutscher Kongress für Versorgungsforschung, 05.–07.10.2016, Berlin. Düsseldorf: German Medical Science GMS Publishing House.
DOI:https://doi.org/10.3205/16dkvf156 (abgerufen am 30.10.2023).
Therapy areas:
Psychiatry
Indications:
Mental disorder
Borchert, J., Schönfelder, T., Kock, S., Horneff, G., Klaus, P., Diesing, J., Heinrich, R., Hagemann, C. & Dally, H. (2023).
Behandlungsmuster in einer polyartikulären juvenilen idiopathischen Arthritis-Population in Deutschland: eine retrospektive Beobachtungsstudie auf Basis von Krankenkassenabrechnungsdaten. RA.28. In: Deutsche Gesellschaft für Rheumatologie e. V. (Hrsg.).
Deutscher Rheumatologiekongress 2023, 30.08–02.09.2023, Leipzig, S. 501.
No DOI/URL available
Therapy areas:
Immunology
Indications:
Juvenile rheumatoid arthritis
Müller, M., Faß, E., Claus, F., Landmesser, U. & Weinhold, I. (2023).
Aufgriff des Schlaganfall- und Blutungsrisikos von Patient:innen mit Vorhofflimmern in GKV-Routinedaten. [Vortrag].
15. dggö Jahrestagung 2023. Deutsche Gesellschaft für Gesundheitsökonomie e.V., 14.03.2023, Hannover. 04.12.2023).
No DOI/URL available
Therapy areas:
Cardiovascular, Renal and Metabolism
Indications:
Cardiac Arrhythmia
Otto, T., Diesing, J., Borchert, J., Heitmann, E., Schloot, N., Lebrec, J., Müller-Wieland, D. & Häckl, D. (2023).
Age-dependent prevalence of type 2 diabetes, cardiovascular risk profiles, and use of diabetes drugs in Germany using health claims data.
Diabetes Obes Metab. (Diabetes, Obesity and Metabolism), 25(3), S. 767–775.
DOI:https://doi.org/10.1111/dom.14924 (abgerufen am 30.10.2023).
Therapy areas:
Cardiovascular, Renal and Metabolism
Indications:
Diabetes Type 2
Garcia, T. B., Kliemt, R., Claus, F., Neumann, A., Soltmann, B., Baum, F., Schwarz, J., Swart, E., Schmitt, J., Pfennig, A., Häckl, D. & Weinhold, I. (2023).
Agreement between self-reports and statutory health insurance claims data on healthcare utilization in patients with mental disorders.
BMC Health Services Research, 23(1), S. 1243.
DOI:https://doi.org/10.1186/s12913-023-10175-6 (abgerufen am 03.01.2024).
Therapy areas:
Psychiatry
Indications:
Mental disorder
Farbod Sedaghat-Hamedani, Carla Zema, Michael Schultze, Tarcyane Garcia, Nils Kossack, Ervant Maksabedian Hernandez, Tobias Bluhmki, Taryn Krause, Johanna Schmoelders, Benjamin Meder.
Assessing the alignment of obstructive hypertrophic cardiomyopathy pharmacological treatments with ESC guidelines in Germany.
European Society of Cardiology (ESC) Congress 2024, 30 August – 02 September 2022, London.
No DOI/URL available
Therapy areas:
Cardiovascular, Renal and Metabolism
Indications:
Cardiomyopathy
Requena, G., Rothnie, K. J., Noorduyn, S. G., Claussen, J., Schultze, M., Kossack, N., Richter, L. M., Vogelmeier, C. F., Beeh, K.-M., Sharma, R., Compton, C. & Ismaila, A. S. (2023).
Adherence to Single and Multiple Inhaled Triple Therapies in Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany, Considering Different Definitions. [Vortrag].
ISPOR Europe 2023. ISPOR, 12.11.2023, Kopenhagen.
Online: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2023-3788/131191 (abgerufen am 03.01.2024).
Therapy areas:
Respiratory
Indications:
COPD
Requena G, Rothnie K, Noorduyn SG, Claussen J, Schultze M, Kossack N, Richter L, Vogelmeier C, Beeh KM, Sharma R, Compton C, Ismaila A.
Adherence to Single and Multiple Inhaled Triple Therapies in Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany, Considering Different Definitions.
Value in Health, Volume 26, Issue 11, S2 (December 2023).
No DOI/URL available
Therapy areas:
Respiratory
Indications:
COPD